CG Oncology, Inc. (CGON) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: August 22, 2025
CG Oncology, Inc. (CGON) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
CG Oncology, Inc. (Stock Symbol: CGON)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
a growing mid-cap opportunity with strong fundamentals.
Financial Performance & Key Metrics Analysis
Market Capitalization: $2052 million - Classified as a
mid-cap growth stock with balanced risk-reward profile.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for CG Oncology, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
CG Oncology, Inc. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share
.
.
CG Oncology, Inc. Stock Price Chart and Technical Analysis
Loading chart data...
Loading CG Oncology, Inc. interactive price chart and technical analysis...
Deep dive into CG Oncology, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if CG Oncology, Inc. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For CG Oncology, Inc.:
P/B Ratio3.06x
Market Cap$2052M
EPS$-1.78
Book Value/Share$8.79
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently CG Oncology, Inc. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For CG Oncology, Inc.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess CG Oncology, Inc.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For CG Oncology, Inc.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal CG Oncology, Inc.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For CG Oncology, Inc.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively CG Oncology, Inc. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For CG Oncology, Inc.:
Understanding Financial Statement Data
What these metrics mean: Key figures from CG Oncology, Inc.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For CG Oncology, Inc.:
Income Statement ($ Millions)
Operating Income$-89M
Net Income$-67M
R&D Expense$69M
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding76M
Growth Metrics (YoY)
EPS Growth-5.4%
CG Oncology, Inc. (CGON) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for CG Oncology, Inc. stock analysis.
Loading fundamental data...
Loading CG Oncology, Inc. comprehensive fundamental analysis and insider trading data...
Latest CG Oncology, Inc. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting CG Oncology, Inc. (CGON) stock price and investment outlook.
CG Oncology, Inc. (NASDAQ:CGON) grew its share prices for a fifth straight day on Monday, surging 25.03 percent to end at $27.97 apiece as investors cheered the promising results of its bladder ...
CG Oncology, Inc. (CGON) shares ended the last trading session 25% higher at $27.97. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.
CG Oncology shares are trading lower by 9.2% during Wednesday's session. The company announced it filed an underwritten public offering of 7.3 million shares of its common stock.
CG Oncology, Inc. (CGON) delivered earnings and revenue surprises of -15.38% and 90.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Andres Y. Maldonado, an analyst from H.C. Wainwright, maintained the Buy rating on CG Oncology, Inc. (CGON – Research Report). The associated price target remains the same with $75.00.
CG Oncology Inc. shares nearly doubled after the biotechnology company raised $380 million in an initial public offering, in the largest single-day increase this year for a US debut.
CG Oncology, Inc. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of CG Oncology, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - CG Oncology, Inc. Stock Forecast
How accurate are CG Oncology, Inc. stock predictions?
Our AI model demonstrates 63% historical accuracy for CGON predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence CG Oncology, Inc. stock price forecasts?
Based on our AI analysis, CG Oncology, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are CG Oncology, Inc. forecasts updated?
CG Oncology, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced CG Oncology, Inc. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for CG Oncology, Inc. stock.
